Issues & Trends

Xcure Corp. Completes Establishment of AXG XCURE Korea… RWA Infrastructure Business Gets Underway in Earnest

Park Jung-Soo
2026-06-30 09:00:27
[Edaily Reporter Park Jung-Soo ] Xcure Corp.(070300)announced on the 30th that it has completed the incorporation of AXG Xcure Corp. and will begin full-scale operations of its regulated infrastructure business connecting global digital asset funds with real-world assets (RWA).
The company plans to pursue the onboarding of global investors through AXG Xcure Corp., the establishment of digital asset-based settlement infrastructure, the screening of RWA assets and review of management structures through AHA Asset Management, and the establishment of security infrastructure for digital assets, custody, and tokenized securities through Naoris Korea.
Xcure Corp. explained that it is focusing on building infrastructure to enable global investors and institutional funds to access RWA assets within the regulated framework, rather than issuing stablecoins or providing payment services for general consumers.
Given that South Korea’s financial settlement infrastructure is highly advanced and regulations—including the real-name system, anti-money laundering (AML), and foreign exchange controls—are strict, the company intends to concentrate on building infrastructure that supports the institution-centric RWA market rather than the general payment market.
AXG Xcure Corp. will be responsible for onboarding overseas investors, developing digital asset-based settlement processes, and exploring the potential for building tokenization interfaces in the future. However, these initiatives will be carried out in compliance with current laws and regulations and the regulatory direction of financial authorities, and will be pursued in collaboration with licensed financial institutions and external specialized agencies.
AHA Asset Management will review the selection of RWA assets—including real estate, bonds, listed stocks, and short-term financial products—and their management structures. Whether these assets are actually commercialized will be determined based on relevant laws and regulations, licensing requirements, investor suitability, and the results of consultations with sales institutions.
Naoris Korea plans to be responsible for building security and internal control infrastructure for institutional investors, including digital asset wallets, custody, electronic signatures, multisig, key management, transaction approval, audit logs, and anomaly detection.
Xcure Corp. stated, “With the establishment of the corporation, we have laid the organizational foundation for our digital asset-based RWA infrastructure business,” adding, “We plan to proceed with future business operations in phases, subject to relevant laws and regulations, the regulatory direction set by financial authorities, and collaboration with licensed financial institutions and external custodians.”
Meanwhile, legislation related to tokenized securities (STOs) and stablecoins is currently underway in South Korea, and detailed licensing requirements and business scopes are being continuously refined. Xcure Corp. plans to develop an RWA infrastructure business model that can be implemented within the regulatory framework.

Economy

Corporation

IT·Science

Economy

[Exclusive] ABLE C&C to Establish European Control Tower in the Netherlands

ABLE C&C(078520)is establishing a subsidiary in the Netherlands to serve as the control tower for its European operations. Following the establishment of its UK subsidiary, the company is setting up a…
2026-08-20 04:25:07

Corporation

"Just Enjoy the Barre Class for Now"... Viewori Targets the Wellness Crowd [Report]

On the afternoon of the 18th, at the Vuori pop-up store in Seongsu-dong, Seongdong-gu, Seoul, a different scene unfolded as I passed through the first and second floors—where clothes were displayed—an…
2026-08-19 15:40:50

IT·Science

[Analysis of K-Bio M&A] Big Pharma on a Biotech Shopping Spree in China… Potential Targets for Major K-Bio M&A Deals (Part 2)

As global Big Pharma companies embark on large-scale mergers and acquisitions (M&A) to overcome the patent cliff and growth limitations, there are increasing instances of Chinese biotech companies bei…
2026-08-20 06:03:02